Transcription of TIMP3, DAPK1, and AKR1B10 in squamous-cell lung cancer

Molecular Biology

Volumn 40, Issue 6, 2006, Pages 945-951

  Mashkova, T D ^a   Oparina, N Yu ^a   Zinov'eva, O L ^a   Kropotova, E S ^a   Dubovaya, V I ^a   Poltaraus, A B ^a   Fridman, M V ^b   Kopantsev, E P ^c   Vinogradova, T V ^c   Zinov'eva, M V ^c   Laktionov, K K ^d   Kasymova, O T ^d   Zborovskaya, I B ^d   Sverdlov, E D ^c   Kisselev, L L ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Gene transcription; Lung adenocarcinoma; Oncogenes; RT PCR; Squamous cell lung cancer; Tumor suppressor genes

Indexed keywords

EID: 33845627678     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893306060148     Document Type: Article

References (40)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M.J. 2006. Cancer statistics, 2006. CA Cancer J. Clin. 56. 6-30.
2. Zaridze D.G. 2004. Epidemiology and etiology of malignant tumors. In: Kantserogenez (Carcinogenesis). Ed. Zaridze D.G. Moscow: Meditsina.
3. Dammann R., Strunnikova M., Schagdarsurengin U., Rastetter M., Papritz M., Hattenhorst U.E., Hofmann H.S., Silber R.E., Burdach S., Hansen G. 2005. CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur. J. Cancer. 41, 1223-1236.
4. Toyooka S., Toyooka K.O., Miyajima K., Reddy J.L., Toyota M., Sathyanarayana U.G., Padar A., Tockman M.S., Lam S., Shivapurkar N., Gazdar A.F. 2003. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin. Cancer Res. 9, 3034-3041.
5. Fukumoto S., Yamauchi N., Moriguchi H., Hippo Y., Watanabe A., Shibahara J., Taniguchi H., Ishikawa S., Ito H., Yamamoto S., Iwanari H., Hironaka M., Ishikawa Y., Niki T., Sohara Y., Kodama T., Nishimura M., Fukayama M., Dosaka-Akita H., Aburatani H. 2005. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11, 1776-1785.
6. Penning T.M. 2005. AKR1B10: A new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 11, 1687-1690.
7. Drynda A., Quax P.H., Neumann M., van der Laan W.H., Pap G., Drynda S., Meinecke I., Kekow J., Neumann W., Huizinga T.W., Naumann M., Konig W., Pap T. 2005. Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J. Immunol. 174. 6524-6531.
8. Han X., Zhang H., Jia M., Han G., Jiang W. 2004. Expression of TIMP-3 gene by construction of a eukaryotic cell expression vector and its role in reduction of metastasis in a human breast cancer cell line. Cell Mol. Immunol. 13, 8-10.
9. Apte S.S., Olsen B.R., Murphy G. 1995. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14,313-14,318.
10. Brueckl W.M., Grombach J., Wein A., Ruckert S., Porzner M., Dietmaier W., Rummele P., Croner R.S., Boxberger F., Kirchner T., Hohenberger W., Hahn E.G., Jung A. 2005. Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI). Cancer Lett. 223, 137-142.
11. Cheng Y.W., Shawber C., Notterman D., Paty P., Barany F. 2006. Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay. Genome Res. 16, 282-289.
12. Kettunen E., Anttila S., Seppanen J.K., Karjalainen A., Edgren H., Lindstrom I., Salovaara R., Nissen A.M., Salo J., Mattson K., Hollmen J., Knuutila S., Wikman H. 2004. Differentially expressed genes in non-small cell lung cancer: Expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet. Cytogenet. 149, 98-106.
13. Riddick A.C., Shukla C.J., Pennington C.J., Bass R., Nuttall R.K., Hogan A., Sethia K.K., Ellis V., Collins A.T., Maitland N.J., Ball R.Y., Edwards D.R. 2005. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br. J. Cancer. 92, 2171-2180.
14. Vazquez-Ortiz G., Pina-Sanchez P., Vazquez K., Duenas A., Taja L., Mendoza P., Garcia J.A., Salcedo M. 2005. Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer. 5, 68.
15. Wikman H., Kettunen E., Seppanen J.K., Karjalainen A., Hollmen J., Anttila S., Knuutila S. 2002. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 21, 5804-5813.
16. Inbal B., Cohen O., Polak-Charcon S., Kopolovic J., Vadai E., Eisenbach L., Kimchi A. 1997. DAP kinase links the control of apoptosis to metastasis. Nature. 390, 180-184.
17. Kogel D., Prehn J.H., Scheidtmann K.H. 2001. The DAP kinase family of pro-apoptotic proteins: Novel players in the apoptotic game. Bioessays. 23, 352-358.
18. Kwong J., Lo K.W., To K.F., Teo P.M., Johnson P.J., Huang D.P. 2002. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 8, 131-137.
19. Simpson D.J., Clayton R.N., Farrell W.E. 2002. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion. Oncogene. 21, 1217-1224.
20. Cao D., Fan S.T., Chung S.S. 1998. Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11,429-11,435.
21. Hyndman D., Bauman D.R., Heredia V.V., Penning T.M. 2003. The aldo-keto reductase superfamily homepage. Chem. Biol. Interact. 143-144, 621-631.
22. Hyndman D.J., Flynn T.G. 1998. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim. Biophys. Acta. 1399, 198-202.
23. Martin H.J., Breyer-Pfaff U., Wsol V., Venz S., Block S., Maser E. 2006. Purification and characterization of AKR1B10 from human liver: Role in carbonyl reduction of xenobiotics. Drug Metab. Dispos. 34, 464-470.
24. Scuric Z., Stain S.C., Anderson W.F., Hwang J.J. 1998. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology. 27, 943-950.
25. Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Lab. Press.
26. Chomczynski P., Mackey K. 1995. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 19, 942-945.
27. Zhu Y.Y., Machleder E.M., Chenchik A., Li R., Siebert P.D. 2001. Reverse transcriptase template switching: A SMART approach for full-length cDNA library construction. Biotechniques. 30, 892-897.
28. Belinsky S.A., Klinge D.M., Dekker J.D., Smith M.W., Bocklage T.J., Gilliland F.D., Crowell R.E., Karp D.D., Stidley C.A., Picchi M.A. 2005. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin. Cancer Res. 11, 6505-6511.
29. Kang S., Kim J.W., Kang G.H., Lee S., Park N.H., Song Y.S., Park S.Y., Kang S.B., Lee H.P. 2006. Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma, and endometrial adenocarcinoma. Int. J. Cancer. 118, 2168-2171.
30. Russo A.L., Thiagalingam A., Pan H., Califano J., Cheng K.H., Ponte J.F., Chinnappan D., Nemani P., Sidransky D., Thiagalingam S. 2005. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin. Cancer Res. 11, 2466-2470.
31. Safar A.M., Spencer H. 3rd, Su X., Coffey M., Cooney C.A., Ratnasinghe L.D., Hutchins L.F., Fan C.Y. 2005. Methylation profiling of archived non-small cell lung cancer: A promising prognostic system. Clin. Cancer Res. 11, 4400-4405.
32. Esteller M., Corn P.G., Baylin S.B., Herman J.G. 2001. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229.
33. Kim Y.T., Park S.J., Lee S.H., Kang H.J., Hahn S., Kang C.H., Sung S.W., Kim J.H. 2005. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung. J. Thorac. Cardiovasc. Surg. 130, 1378.
34. Lu C., Soria J.C., Tang X., Xu X.C., Wang L., Mao L., Lotan R., Kemp B., Bekele B.N., Feng L., Hong W.K., Khuri F.R. 2004. Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers. J. Clin. Oncol. 22, 4575-4583.
35. Soria J.C., Rodriguez M., Liu D.D., Lee J.J., Hong W.K., Mao L. 2002. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 62, 351-355.
36. Yanagawa N., Tamura G., Oizumi H., Takahashi N., Shimazaki Y., Motoyama T. 2003. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 94, 589-592.
37. Girard L., Zochbauer-Muller S., Virmani A.K., Gazdar A.F., Minna J.D. 2000. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60, 4894-4906.
38. Pastor A., Menendez R., Cremades M.J., Pastor V., Llopis R., Aznar J. 1997. Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: A Bayesian analysis. Eur. Respir. J. 10, 603-609.
39. Thun M.J., Henley S.J., Calle E.E. 2002. Tobacco use and cancer: An epidemiologic perspective for genetics. Oncogene. 21, 7307-7325.
40. Powell C.A., Spira A., Derti A., DeLisi C., Liu G., Borczuk A., Busch S., Sahasrabudhe S., Chen Y., Sugarbaker D., Bueno R., Richards W.G., Brody J.S. 2003. Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 29, 157-162.